We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > FTD

News List

Cellectar Receives FTD for Diffuse Large B-Cell Lymphoma Treatment contractpharma
July 10, 2019
Drug conjugate, CL131, delivers cytotoxic radiation directly and selectively to cancer cells.
Passage Bio receives $115m in funding to address CNS diseases pharmaceutical-technology
February 18, 2019
Gene therapy company Passage Bio has launched in the US with $115.5m series A funding to develop AAV-delivered therapies for the treatment of rare monogenic central nervous system (CNS) disorders.....
FDA Grants Orphan-drug Designation for LMTX in Frontotemporal Dementia americanpharmaceuticalreview
December 11, 2018
TauRx announced the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to LMTX for the "treatment of frontotemporal dementia.” The term Frontotemporal Dementia (FTD) covers.....